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Abstracts / Osteoarthritis and Cartilage 21 (2013) S9–S62S48markers measured (Figure 1C). This phenotype represented the sole AF
cell type identiﬁed thus far.
Conclusions: We generated the ﬁrst human annulus ﬁbrosis cell lines
and present an detailed characterization of their phenotype in
comparison to our novel nucleus pulposus cell lines. The distinct
migratory behavior of isolated immortal AF clones, in contrast to that of
cell pools, suggests that distinct phenotype may be preferentially
immortalized and, by inference, that functionally different subtypes
may exist in AF cell population. Our future investigations will focus on
integrin expression, in relation to culturing them on deﬁned (e.g.
ﬁbronectin, collagen) surfaces, as such conditions were suggested to
mimic AF-like conditions.ĂThis research forms part of the Project P2.01 IDiDAS of the research
program of the BioMedical Materials institute, cofunded by the Dutch
Ministry of Economic Affairs, Agriculture and Innovation.77
THE TRANSCRIPTION FACTOR MOHAWK PLAYS AN IMPORTANT ROLE
FOR MAINTAINING HUMAN ACL HOMEOSTASIS AND LIGAMENT/
TENDON DIFFERENTIATION OF MESENCHYMAL STEM CELLS
K. Otabe, H. Nakahara, A. Hasegawa, F. Ayabe, T. Matsukawa, M.K.
Lotz, H. Asahara. The Scripps Res. Inst., La Jolla, CA, USA
Background/Purpose: Mohawk homeobox (MKX) has been demon-
strated as a tendon and ligament speciﬁc transcriptional factor. MKX
knock-out mice showed hypoplastic tendons throughout the body, due
to reduced type I collagen production in tendon cells. However, in
mature human tendon or ligament tissues, the function of MKX has not
been fully understood. The aims of this study are to characterize the
expression of MKX in normal human knee joints and osteoarthritis (OA)
affected knee joints and to investigate the role of MKX in human liga-
ment homeostasis and in ligament/tenogenic differentiation of
mesenchymal stem cells.
Methods: Human ACL specimens were obtained from the knee joints at
autopsy within 24-48 hours postmortem with approval of the Scripps
Human Subjects Committee. 7 normal donors (mean  SD age 33.6 
11.7 years) and 8 donors with OA (mean SD age 77.511.5 years) were
analyzed. All cartilage surfaces were graded macroscopically. ACL
degeneration was assessed macroscopically and histologically using
quantitative scoring systems. ACL tissues were analyzed for the
expression of MKX by immunohistochemistry and quantitative RT-PCR
assays. Primary cultured human ACL cells were stimulated with IL-1b to
examine whether this pro-inﬂammatory cytokine modulates MKX
expression. Moreover, in order to examine the function of MKX in ECM
production and differentiation in these cells, we performedMKX knock-
down by MKX speciﬁc siRNA. To examine the function of MKX in ECM
production and differentiation in human bone marrow mesenchymal
stem cells (BMMSC) (n¼6 from 2 donors), we performed over-expres-
sion of MKX by adenoviral vector and analyzed gene and protein levels
of COL1a1, and tenascin b (TNXb), important ECM components of ACL.Results: The expression of MKX mRNA was remarkably decreased
during OA development. In addition, the expression of COL1a1 was also
decreased in the OA group. Immunohistochemistry revealed that the
percentage of MKX positive cells was signiﬁcantly reduced in OA group.
In primary cultured human ACL cells, the expression of MKX was
signiﬁcantly reduced by the treatment of IL-1b. The expression of ECM
genes COL1a1 and TNXb and transcription factor Scleraxis (SCX), which
is a speciﬁc regulator of the tendon/ligament lineage, were down-
regulated by IL-1b treatment. On the other hand, SOX9, which is
involved in the modulation of chondrocyte like phenotype, was up-
regulated by IL-1b treatment. The expression of COL1a1 and TNXbwere
decreased by MKX speciﬁc siRNA treatment, while SOX9 was increased.
By contrast, the expression of COL1a1 and TNXb were increased by
overexpression of MKX in BMMSCs.
Conclusion: To our knowledge, this is the ﬁrst report to investigate the
MKX expression and function in human ligaments. The present ﬁndings
demonstrate that the ACL in OA-affected joints are deﬁcient in MKX
expression and this is associated with reduced ECM production.
Reduced MKX in OA may be due to inﬂammatory stimuli such as IL-1b.
In cultured ACL cells, and in mesenchymal stem cells MKX promotes the
maintenance and induction of tenocyte phenotype. Thus, MKX is a key
factor that is required for maintenance of ligament structure and
function.78
GENE EXPRESSION VARIATION IN HUMAN MENISCUS: MOLECULAR
AND CLINICAL IMPLICATIONS FOR CARTILAGE HOMEOSTASIS AND
EARLY OSTEOARTHRITIS DEVELOPMENT
M.F. Rai, L.J. Sandell, D. Patra, R.H. Brophy.Washington Univ. Sch. of Med.,
St. Louis, MO, USA
Purpose: Meniscal tears may be critical indicators of future osteoar-
thritis. Our objective was to ascertain the metabolic state of the tissue at
the time of arthroscopic surgery to repair the meniscus. Transcriptome
analysis of the meniscal tissues was performed to probe the molecular
proﬁle related to age and arthritic changes in articular cartilage.
Methods: Humanmeniscus tissues were acquired from patients (n¼12)
undergoing arthroscopic partial meniscectomy. The degree of chond-
rosis of articular cartilage was recorded at the time of arthroscopic
meniscal resection. RNA preparations from these meniscal tissues were
subjected to microarray analysis followed by validation of fold-change
differences by QuantiGene Plex assay. The fold-change variation in gene
expression was computed for either age (young versus old) or presence
or absence of chondrosis and the relevant biological processes were
investigated computationally.
Results: We identiﬁed, for the ﬁrst time, a set of comprehensive,
differentially expressed genes from resected meniscus tissues. The
population of differentially regulated genes identiﬁed differed with age
or degree of chondrosis. We identiﬁed 866 genes differentially regu-
lated (>1.5-fold; P< 0.05) by age (373 up; 493 down) and 49 genes by
degree of chondrosis (23 up; 26 down). Notably, a number of biologi-
cally signiﬁcant genes down-regulatedwith age are extracellular matrix
genes such as COL2A1 (10.38-fold), CHAD (6.73-fold), COL11A2 (6.14-
fold), COL9A2 (5.99-fold), CILP2 (4.32-fold) and ACAN (2.52-fold), which
is suggestive of degenerative changes in the meniscus with age. Some of
the genes upregulated with age include immune response and
inﬂammation genes [HLA-DRB5 (15.73-fold), HLA-DRB1 (15.01-fold), IL-
7R (2.83-fold), CX3CR1 (2.28-fold), CCL8 (1.56-fold)] and cell prolifer-
ation genes [DLGAP5 (2.38-fold), PCNA (1.63-fold), CDC25C (1.61-fold)].
The gene expression data was used to generate functional and molec-
ular networks using Gene Relational Network of InterActing Elements
(GRANITE) and the resulting gene interactions are shown in the Figure.
The network analysis shows that differentially expressed genes are
linked with each other indicating their plausible contribution in similar
pathways.
Taken, together our data suggest that age-related decrease in matrix
synthesis and increase in inﬂammatory events may promote degener-
ative meniscal tears with subsequent chondral changes ultimately
leading to osteoarthritis development.
Conclusions: Transcriptome analysis identiﬁed deﬁnitive subtypes of
meniscal damage that could be segregated molecularly by age or degree
of chondrosis. These studies provide a molecular link between meniscal
damage and cartilage degeneration.
